REX Peptide ETF (NASDAQ:PEPT) Shares Shorted: Short Interest Up 3,844.0% in October

REX Peptide ETF (NASDAQ:PEPT) was the target of a large growth in short interest in the month of October. As of October 30th, there was short interest totaling 8,874 shares, a growth of 3,844.0% from the October 15th total of 225 shares. Based on an average trading volume of 7,975 shares, the short-interest ratio is presently 1.1 days. Approximately 7.4% of the shares of the company are short sold.

REX Peptide ETF Trading Down 0.4%

Shares of PEPT stock traded down $0.11 during trading on Tuesday, reaching $27.71. 5,029 shares of the company’s stock traded hands, compared to its average volume of 7,117. REX Peptide ETF has a 1 year low of $25.06 and a 1 year high of $28.14. The stock has a market capitalization of $3.33 million and a P/E ratio of 6,423.27.

REX Peptide ETF (NASDAQ: PEPT) is an exchange-traded fund designed to provide targeted exposure to companies involved in the development, production, and commercialization of peptide-based medicines and related technologies. Rather than operating as a traditional company, the fund holds a portfolio of businesses participating in the broader peptide therapeutics industry. The fund’s investment focus may include pharmaceutical and biotechnology companies developing peptide treatments, as well as businesses supporting peptide research, drug discovery, manufacturing, delivery systems, and related healthcare applications.